HUE060167T2 - Diabéteszes nefropátia vagy diabéteszes vesebetegségek megelõzésére vagy kezelésére szolgáló vegyület - Google Patents
Diabéteszes nefropátia vagy diabéteszes vesebetegségek megelõzésére vagy kezelésére szolgáló vegyületInfo
- Publication number
- HUE060167T2 HUE060167T2 HUE16723346A HUE16723346A HUE060167T2 HU E060167 T2 HUE060167 T2 HU E060167T2 HU E16723346 A HUE16723346 A HU E16723346A HU E16723346 A HUE16723346 A HU E16723346A HU E060167 T2 HUE060167 T2 HU E060167T2
- Authority
- HU
- Hungary
- Prior art keywords
- diabetic
- prophylaxis
- compound
- treatment
- kidney disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2014843 | 2015-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE060167T2 true HUE060167T2 (hu) | 2023-02-28 |
Family
ID=56014996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16723346A HUE060167T2 (hu) | 2015-05-22 | 2016-05-12 | Diabéteszes nefropátia vagy diabéteszes vesebetegségek megelõzésére vagy kezelésére szolgáló vegyület |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10676452B2 (hu) |
| EP (1) | EP3297625B1 (hu) |
| JP (2) | JP6967456B2 (hu) |
| CN (1) | CN107660148B (hu) |
| AU (1) | AU2016268975B2 (hu) |
| BR (1) | BR112017024854B1 (hu) |
| CA (1) | CA2986300C (hu) |
| CL (1) | CL2017002960A1 (hu) |
| DK (1) | DK3297625T3 (hu) |
| ES (1) | ES2927699T3 (hu) |
| HU (1) | HUE060167T2 (hu) |
| MX (1) | MX2017014912A (hu) |
| PL (1) | PL3297625T3 (hu) |
| PT (1) | PT3297625T (hu) |
| WO (1) | WO2016188766A1 (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL2010010C2 (en) * | 2012-12-19 | 2014-06-23 | Sulfateq B V | Compounds for protection of cells. |
| PL3297625T3 (pl) * | 2015-05-22 | 2022-11-14 | Sulfateq B.V. | Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek |
| EP3672592A1 (en) | 2017-08-25 | 2020-07-01 | Sulfateq B.V. | 6-chromanol derivatives for use as a medicament |
| EP3672593A1 (en) | 2017-08-25 | 2020-07-01 | Sulfateq B.V. | Medicaments for the treatment of vasoconstriction related diseases or disorders |
| PL3713564T3 (pl) | 2017-11-22 | 2024-04-08 | Khondrion Ip B.V. | Związki jako inhibitory mPGES-1 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4681890A (en) | 1984-10-30 | 1987-07-21 | Kuraray Co., Ltd. | 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same |
| EP0202580B1 (en) | 1985-05-13 | 1990-03-28 | Kuraray Co., Ltd. | 3,4-dihydrobenzopyran derivatives |
| CA1338012C (en) | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
| US5266709A (en) | 1989-03-13 | 1993-11-30 | Ono Pharmaceutical Co., Ltd. | Benzopyran derivatives |
| US5506245A (en) * | 1992-10-12 | 1996-04-09 | Adir Et Compagnie | Thiazolidinedione compounds |
| US5457109A (en) | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| FR2756284B1 (fr) | 1996-11-26 | 2000-04-28 | Adir | Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6335445B1 (en) | 1997-03-24 | 2002-01-01 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| EP0894089B9 (en) | 1997-05-02 | 2003-04-02 | Dr. Reddy's Laboratories Ltd. | Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| AR019190A1 (es) * | 1998-07-08 | 2001-12-26 | Sod Conseils Rech Applic | Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos |
| US6768008B2 (en) | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| EP1598345A4 (en) | 2003-02-26 | 2006-03-22 | Shanghai Inst Materia Medica | BENZOPYRANE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USES THEREOF |
| WO2005012293A1 (ja) | 2003-08-01 | 2005-02-10 | Nippon Soda Co., Ltd. | フェニルアゾール化合物、製造法および抗酸化薬 |
| US7514461B2 (en) * | 2003-09-19 | 2009-04-07 | Edison Pharmaceuticals, Inc. | Chroman derivatives |
| PL2872497T5 (pl) * | 2012-07-12 | 2020-02-28 | Khondrion Ip B.V. | Pochodne chromanylowe do leczenia choroby mitochondrialnej |
| NL2010010C2 (en) | 2012-12-19 | 2014-06-23 | Sulfateq B V | Compounds for protection of cells. |
| PL3297625T3 (pl) * | 2015-05-22 | 2022-11-14 | Sulfateq B.V. | Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek |
-
2016
- 2016-05-12 PL PL16723346.9T patent/PL3297625T3/pl unknown
- 2016-05-12 US US15/576,290 patent/US10676452B2/en active Active
- 2016-05-12 JP JP2017560691A patent/JP6967456B2/ja active Active
- 2016-05-12 WO PCT/EP2016/060731 patent/WO2016188766A1/en active Application Filing
- 2016-05-12 HU HUE16723346A patent/HUE060167T2/hu unknown
- 2016-05-12 BR BR112017024854-9A patent/BR112017024854B1/pt active IP Right Grant
- 2016-05-12 EP EP16723346.9A patent/EP3297625B1/en active Active
- 2016-05-12 ES ES16723346T patent/ES2927699T3/es active Active
- 2016-05-12 MX MX2017014912A patent/MX2017014912A/es unknown
- 2016-05-12 CA CA2986300A patent/CA2986300C/en active Active
- 2016-05-12 CN CN201680029709.1A patent/CN107660148B/zh active Active
- 2016-05-12 PT PT167233469T patent/PT3297625T/pt unknown
- 2016-05-12 AU AU2016268975A patent/AU2016268975B2/en active Active
- 2016-05-12 DK DK16723346.9T patent/DK3297625T3/da active
-
2017
- 2017-11-21 CL CL2017002960A patent/CL2017002960A1/es unknown
-
2020
- 2020-06-08 US US16/895,007 patent/US20210024485A1/en not_active Abandoned
-
2021
- 2021-04-23 JP JP2021073064A patent/JP2021120381A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017024854B1 (pt) | 2023-12-26 |
| JP2021120381A (ja) | 2021-08-19 |
| JP6967456B2 (ja) | 2021-11-17 |
| US10676452B2 (en) | 2020-06-09 |
| EP3297625B1 (en) | 2022-07-06 |
| US20210024485A1 (en) | 2021-01-28 |
| PT3297625T (pt) | 2022-09-27 |
| BR112017024854A2 (pt) | 2018-08-14 |
| CL2017002960A1 (es) | 2018-03-16 |
| ES2927699T3 (es) | 2022-11-10 |
| CA2986300C (en) | 2024-02-20 |
| CN107660148A (zh) | 2018-02-02 |
| PL3297625T3 (pl) | 2022-11-14 |
| AU2016268975B2 (en) | 2021-08-12 |
| US20180170892A1 (en) | 2018-06-21 |
| JP2018520106A (ja) | 2018-07-26 |
| AU2016268975A1 (en) | 2017-11-30 |
| CN107660148B (zh) | 2021-03-09 |
| MX2017014912A (es) | 2018-06-13 |
| WO2016188766A1 (en) | 2016-12-01 |
| CA2986300A1 (en) | 2016-12-01 |
| DK3297625T3 (da) | 2022-10-17 |
| EP3297625A1 (en) | 2018-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1247202A1 (zh) | 用於治療癌症的化合物 | |
| HK1251257A1 (zh) | 用於醫治疾病的外泌體的用途 | |
| HK1244280B (zh) | 用於治療感染性疾病的吡嗪化合物 | |
| IL253945A0 (en) | kdm1a inhibitors to treat the disease | |
| IL247111A0 (en) | causes the prevention of or treatment of kidney disease | |
| IL259996A (en) | Combinations for cancer treatment | |
| LT3122358T (lt) | Egfr ir cmet inhibitorių deriniai, skirti vėžio gydymui | |
| IL285077A (en) | Compounds for the treatment of cancer | |
| HUE044021T2 (hu) | Akne kezelésére szolgáló készítmény | |
| IL259297A (en) | Heterocyclic compounds for the treatment of disease | |
| HUE060167T2 (hu) | Diabéteszes nefropátia vagy diabéteszes vesebetegségek megelõzésére vagy kezelésére szolgáló vegyület | |
| HK1252245A1 (zh) | 用於治療癌症的核苷酸 | |
| HK1256883A1 (zh) | 治療多囊腎病的方法 | |
| SI3302573T1 (sl) | Sestavek za zdravljenje možganskih lezij | |
| GB201515244D0 (en) | Treatment of inflammatory disease or condition | |
| HK1246679A1 (zh) | 絲蟲病的治療 | |
| KR20180084983A (ko) | 암의 치료를 위한 피리미도-피리미다지논의 용도 | |
| GB201510870D0 (en) | Treatment of infarction | |
| ZA201704589B (en) | Compounds for the treatment of cancer | |
| GB201621398D0 (en) | Treatment of emt-associated disease | |
| AU2015900978A0 (en) | Compositions for the treatment of kidney disease | |
| GB201504413D0 (en) | Treatment of disease | |
| AU2015902358A0 (en) | Treatment of inflammatory disease | |
| GB201512635D0 (en) | Uses of therapeutic compounds | |
| AU2014901885A0 (en) | Compounds for the treatment of antibacterial infections |